Literature DB >> 11529776

Stereocontrolled synthesis of the northern part of potent proteasome inhibitor TMC-95A.

M Inoue1, H Furuyama, H Sakazaki, M Hirama.   

Abstract

[reaction: see text]. A protected version of the northern part of TMC-95A, a potent and selective proteasome inhibitor, was synthesized with full stereochemical control. Highlights of this synthesis include (i) a (Z)-selective Mizoroki-Heck reaction to construct the oxyindole portion, (ii) a diastereoselective epoxidation, (iii) a 6-endo selective epoxide opening by Boc carbonyl group to establish the stereochemistry of C6, and (iv) a 1,3-elimination reaction of the L-allo-threonine derivative under Mitsunobu conditions to afford the (Z)-1-propenylamine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529776     DOI: 10.1021/ol016303v

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  3 in total

1.  A concise, total synthesis of the TMC-95A/B proteasome inhibitors.

Authors:  Brian K Albrecht; Robert M Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-26       Impact factor: 11.205

2.  Total synthesis of TMC-95A and -B via a new reaction leading to Z-enamides. Some preliminary findings as to SAR.

Authors:  Songnian Lin; Zhi-Qiang Yang; Benjamin H B Kwok; Michael Koldobskiy; Craig M Crews; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2004-05-26       Impact factor: 15.419

3.  Facile synthesis of functionalized spiro[indoline-3,2'-oxiran]-2-ones by Darzens reaction.

Authors:  Qin Fu; Chao-Guo Yan
Journal:  Beilstein J Org Chem       Date:  2013-05-13       Impact factor: 2.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.